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Abstract
Homo sapiens J domain protein (HSJ1) is a J-domain containing co-chaperone that is known to stimulate ATPase activity of
HSP70 chaperone, while it also harbors two ubiquitin (Ub)-interacting motifs (UIMs) that may bind with ubiquitinated
substrates and potentially function in protein degradation. We studied the effects of HSJ1a on the protein levels of both
normal and the disease–related polyQ-expanded forms of ataxin-3 (Atx3) in cells. The results demonstrate that the N-
terminal J-domain and the C-terminal UIM domain of HSJ1a exert opposite functions in regulating the protein level of
cellular overexpressed Atx3. This dual regulation is dependent on the binding of the J-domain with HSP70, and the UIM
domain with polyUb chains. The J-domain down-regulates the protein level of Atx3 through HSP70 mediated proteasomal
degradation, while the UIM domain may alleviate this process via maintaining the ubiquitinated Atx3. We propose that co-
chaperone HSJ1a orchestrates the balance of substrates in stressed cells in a Yin-Yang manner.
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Introduction
The homeostasis of proteins is vital to the physiological activities
and health of eukaryotic cells [1,2], which is influenced by many
intrinsic and environmental factors. Besides synthesis, protein
folding and degradation are the two major post-translational factors
to maintain this particular process [3]. However, many reasons
endogenously or exogenously, such as gene mutation, protein
overexpression and dislocation, or chemical stresses, can cause
protein misfolding or aberrant degradation [4,5,6]. For a protein,
the failure to refold to its native stateorto beeliminated forrecycling
often leads to protein aggregation, dysfunction, and ultimately cell
death, which is implicated inmany neurodegenerative diseases, such
as Alzheimer’s disease, Huntington’s disease and Spinocerebellar
ataxias [5,6,7]. A histopathological hallmark of these diseases is that
the misfolded proteins form neuronal intracellular inclusions. Many
pathological polyglutamine (polyQ) containing inclusions have been
found to be co-localized with HSP70 and its co-chaperones,
ubiquitin(Ub)and proteasomesubunits[8,9,10,11].Overexpression
of HSP70 and its co-chaperone can reduce inclusion formation and
suppress the cell death [12,13]. These findings suggest that
molecular chaperones and the Ub-proteasome system (UPS) are
contributable to refold or eliminate the misfolded proteins before
their aggregation [14]. Combination of these functions plays a
central role in the cellular stress response to maintain protein
homeostasis in eukaryotes [15,16,17].
It has been well studied that molecular chaperones and their co-
chaperones work together to regulate diverse cell activities
including protein folding, transportation and degradation [18].
Among the various co-chaperones, the J-domain (JD) containing
proteins (J proteins) are the most popular. There are at least 50 J
proteins encoded by the human genome [19]. Homo sapiens J
domain protein (HSJ1), also called DNAJB2, is a JD-containing
co-chaperone and preferentially expressed in neural tissues [20].
There are two alternatively spliced isoforms identified, HSJ1a and
HSJ1b. HSJ1a has been reported to function in regulating the
ATPase activity of HSP70 and substrate binding [21]. Besides the
conserved J-domain, HSJ1a also harbors two Ub-interacting
motifs (UIMs), which make it a special co-chaperone implicated in
linking the molecular chaperone and ubiquitination associated
degradation [15,22].
Ataxin-3 (Atx3) is a well known polyQ-containing protein;
abnormal expansion of the polyQ tract is responsible for
spinocerebellar ataxia type 3 (SCA3) or Machado–Joseph disease
[23,24]. There are literatures reported that overexpression of
polyQ-expanded Atx3 may cause heat shock response, and some
chaperones and co-chaperones function in orchestrating the
protein levels and cellular toxicity of polyQ-expanded Atx3
[9,25,26]. For example, HSP40 and HSP70 were reported to
localize in the intranuclear aggregates formed by mutant ataxin-3
and that overexpression of HSP40 reduces aggregation of
truncated and full-length Atx3 [9]. In this research, we applied
exogenous overexpressed Atx3, normal with 22 glutamines
(Atx322Q) or polyQ expanded (Atx371Q), to mimic the high
protein level of Atx3 in cells and to investigate the function of
HSJ1a in cell stress response through potential cooperation
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dation. We found that HSJ1a can dually regulate the proteasomal
degradation of the cellular overexpressed Atx3 through maintain-
ing a balance between HSP70 binding and Ub binding. A
schematic model for Yin-Yang regulating the substrate level by co-
chaperones in stressed eukaryotic cells is also proposed and
discussed.
Results
HSJ1a dually regulates the protein level of Atx3
HSJ1a is a co-chaperone that was reported to interact with
HSP70 and regulate its chaperoning activities [21]. It is
predominantly comprised of an N-terminal HSP70-binding J-
domain (JD) and two putative Ub-interacting motifs (UIMs) in
the C-terminus (Fig. 1A). To get insights into the possible
mechanism underlying that HSJ1a regulates cellular metabolism
and affects the protein level of Atx3, we focused the research on
the protein level of Atx3 in cellular models by Western blotting
and microscopic imaging experiments (Fig. 1). As a result, HSJ1a
can slightly increase the protein level of normal Atx3 (Atx322Q)
as compared with the mock vector (Fig. 1B & 1C), suggesting
that HSJ1a may have regulatory function on the fate of Atx3 via
some yet unidentified pathways. To address this issue, we
prepared two HSJ1a fragments, JD (residues 1-91) and JD-
deletion (DJD, 91-274), respectively (Supplemental Fig. S1A).
Co-expression with the JD fragment dramatically decreases the
protein level of Atx3 to an undetectable extent (Fig. 1B & 1C).
On the other hand, co-expression with the DJD fragment largely
increases the level of Atx3. Confocal microscopic imaging
exhibits that the JD fragment of HSJ1a can almost eliminate
cellular Atx3, whereas the DJD fragment significantly increase
the Atx3 amount (Fig. 1D). These results demonstrate that
HSJ1a dually regulates the steady state of Atx3 level through
both the J-domain that decreases the Atx3 amount and the UIM
domain that increases it.
To get information whether the change of Atx3 amount caused
by HSJ1a or its fragments in cells is due to the different protein
expression efficiency, we examined the transcriptional levels of the
constructs by measuring the mRNA amounts (Fig. S1B). Although
the mRNA amount of Atx3 exhibits a slight increase in the
presence of the JD fragment as compared with others, the
difference in mRNA levels cannot account for the remarkable
decrease of Atx3 amount caused by the J-domain.
Chaperone binding is important for the function of the J-
domain
Since HSJ1a dually regulates the protein level of Atx3 by
harboring two functional domains, we explored whether this
dual regulation is dependent on the binding to chaperone or
Ub. The physical interaction between HSJ1 and HSP70 has
been studied in vitro [21,27]. Our study indicates that the J-
domain of HSJ1a is sufficient to bind with HSP70 (data not
shown). The binding site of HSP70 on the J-domain has been
well defined to the conserved HPD tripeptide [28,29]. We
replaced the HPD site with QPN on the J-domain of HSJ1a
(hereafter referred to JD
mut, Fig. S1A). GST pull-down
experiment shows that this mutation disrupts the interaction
between HSJ1a and HSP70 (Fig. 2A). In contrast to the wild-
type J-domain, JD
mut loses the ability to reduce the protein level
of Atx3 (Fig. 2B, lane 4). Moreover, co-expression of JD with
Atx3 decreases the amount of Atx3 at a dose-dependent manner
(Fig. 2C & 2D). However, JD
mut without HPD site largely
w e a k e n st h i sr e d u c i n ge f f e c t .T h i sm e a n st h a ti n t e r a c t i o n
between the J-domain and HSP70 chaperone is essential for
the HSJ1a functionality. Then, we generated the same HPD-to-
QPN mutation on full-length HSJ1a (referred HSJ1a-JD
mut). In
comparison with JD
mut, this HSJ1a mutant also loses the ability
to reduce the Atx3 amount in cells (see Fig. 3A, lane 3), which
exhibits similar effect with the DJD fragment (Fig. 1B). Taken
together, these results suggest that the regulatory function of the
J-domain on Atx3 level is dependent on its specific interaction
with the HSP70 chaperone.
Ub binding is important for the function of the UIM
domain
Next, we tested whether the increased level of Atx3 by HSJ1a
is dependent on the interaction between the UIM domain and
Ub chains. The C-terminal UIM domain of HSJ1a contains two
UIM motifs (UIM12, residues 206-272) (Fig. 1A). We studied the
interaction of UIM12 with isopeptide-linked diUb chains in vitro
by using biophysical techniques. The data from isothermal
titration calorimetry (ITC) shows that UIM12 binds to K48-diUb
with a higher affinity than to K63-diUb (Fig. S2A & S2B). NMR
titration indicates that the second UIM (UIM2) is more important
than the first UIM (UIM1) for binding with K48- or K63-diUb
(Fig. S2C, S2D & S2E), which is consistent with the previous
report [30]. Then we substituted the two conserved Ser and Glu
residues with Ala in each UIM in the context of full-length HSJ1a
(referred to HSJ1a-UIM
mut, Fig. S1A). Co-IP experiment shows
that this mutation significantly disrupts the interaction with
polyUb chains in cells (Fig. S2F). The UIM mutation indeed
abolishes the increasing effect of HSJ1a on the protein level of
Atx3 (Fig. 3A, lane 4), exhibiting similar effect with the JD
fragment that significantly decreases the level of Atx3 (Fig. 1B).
These effects on the Atx3 levels are also confirmed by the
experiments under an HSJ1a dose-dependent manner (Fig. 3B).
Immuno-fluorescence imaging also directly shows that HSJ1a-
JD
mut significantly increases the protein level of Atx3, whereas
HSJ1a-UIM
mut considerably decreases it (Fig. 3C). These results
clearly indicate that regulation of Atx3 by HSJ1a is somehow
related to the binding of its C-terminal UIM domain to Ub
chains.
HSJ1a regulates degradation of Atx3 through a
proteasome pathway
Since regulation of Atx3 by HSJ1a is not possibly related to the
transcriptional way (Fig. S1B), the fluctuation in the Atx3 amount
is somehow associated with the degradation that may be
modulated by HSJ1a. Previous studies indicate that Atx3 is
degraded by the Ub-proteasome pathway [31]. We examined
whether the J-domain of HSJ1a promotes the degradation of Atx3
through a proteasome or lysosome pathway. We treated the HEK
293T cells that overexpress Atx3 and HSJ1a-UIM
mut with a
proteasome or lysosome inhibitor, and then examined the Atx3
levels of the cell lysates. In the presence of the proteasome
inhibitor lactacystine, the Atx3 level is recovered to that as the
control vector only (Fig. 4A). However, the lysosome inhibitor,
ammonium chloride (NH4Cl) has only a slight influence on the
Atx3 level, similar to non-treatment of the cells. In the cells
transfected with Atx3 and HSJ1a or HSJ1a-UIM
mut, inhibition of
proteasome activity by MG132 results in a remarkable accumu-
lation of Atx3 as in the case of mock vector (Fig. 4B & 4C).
However, proteasome inhibition has no considerable effect on the
amount of Atx3 when the cells were transfected with Atx3 and
HSJ1a-JD
mut (Fig. 4C), because HSJ1a-JD
mut has exerted the
effect on accumulating Atx3 protein to a saturation before the
Dual Regulation of Ataxin-3 by HSJ1a
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degradation of Atx3 modulated by HSJ1a may undergo through a
proteasome pathway.
As known, ubiquitination of a protein substrate is required for
its proteasomal degradation [32,33], thus the degradation of Atx3
modulated by HSJ1a may also be associated with ubiquitination of
Figure 1. HSJ1a dually regulates the protein level of Atx3 in cells. A, Domain architectures of HSJ1a and Atx3. A polyQ expansion is
sometimes occurred in the pathogenic Atx3. B, Effects of HSJ1a and its fragments on the protein levels of normal Atx3. HA-tagged Atx322Q and Myc-
HSJ1a or its fragments (with half DNA amount) were co-transfected into HEK 293T cells. About 48 hrs after transfection, the cell lysates were
subjected to immunoblotting with anti-HA, anti-Myc or anti-actin antibody. Atx3 (Atx322Q), normal Atx3 with a polyQ tract of 22 Gln residues; JD, the
N-terminal J-domain fragment (residues 1-91); DJD, the C-terminal JD-deleted fragment (91-274). C, Quantitative analysis of the Atx322Q level. The
data are from (B) by using Scion Image and shown as means 6 S.D. (n=3). ** p,0.01, *** p,0.001. D, Visualization of the cellular protein levels of
Atx3 regulated by HSJ1a and its fragments by immuno-fluorescence microscopic imaging. Atx3 is stained with anti-HA antibody (green), HSJ1a and
its fragments are stained with anti-Myc antibody (red), and nuclei are stained with Hoechst (blue). Scale bar=20 mm.
doi:10.1371/journal.pone.0019763.g001
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its mutants into HEK 293T cells, treated the cells with proteasome
inhibitor MG132, and then detected the ubiquitination level of
Atx3 by co-immunoprecipitation. As a result, both HSJ1a and
HSJ1a-JD
mut can promote accumulation of the ubiquitinated Atx3
in cells (Fig. 4D), as compared with the mock vector. However, the
HSJ1a-UIM
mut loses the ability to accumulate the ubiquitinated
Atx3, which can only be detected in the presence of MG132.
Taken together, these results demonstrate that HSJ1a down-
regulates the degradation of Atx3 through accumulating the
ubiquitinated Atx3 involved in the Ub-proteasome pathway.
Since Atx3 itself also harbors two UIM motifs near the polyQ
region that may also recruit ubiquitinated substrates (Fig. 1A),
there is still a possibility that the ubiquitinated proteins we have
observed in the gels are not Atx3 itself but other substrates. To
exclude this possibility, we prepared some mutations in the UIM
region of Atx3 (S236A/S256A, Atx3-UIM
mut) to disrupt its
binding with Ub chains [34,35]. The results show that HSJ1a
exerts the similar effect on the UIM mutant of Atx3 (Fig. S3).
Therefore, we conclude that the UIM domain of HSJ1a plays an
important role in protecting the ubiquitinated Atx3 from
proteasomal degradation.
Atx3 is a substrate of HSP70-mediated proteasomal
degradation
As the J-domain binds with HSP70 chaperone and promotes
degradation of Atx3 (Fig. 2), it is most likely that HSJ1a regulates
the Atx3 level though an HSP70-mediated degradation pathway.
It has been established that HSP70 and its co-chaperones regulate
the proteasomal degradation of some short-lived or aberrant
proteins, such as polyQ-containing proteins [9,36,37]. To
investigate whether HSP70 is a direct mediator for degradation
of Atx3 modulated by HSJ1a, we treated the cells with ATPase
inhibitors of HSP70 [38]. As shown, Azure C treatment does lead
to a significant increase of Atx3 (Fig. 5A). Methylene blue (MB),
another HSP70 inhibitor proved to inhibit the ATPase activity
and to regulate degradation of polyQ-containing proteins [39], has
the similar effect on the Atx3 amount (data not shown).
Interestingly, Azure C treatment exhibits similar effect with
MG132 treatment, both of which lead to accumulation of the
Atx3 protein (Fig. 5A & 5B). Similar to inhibition of proteasome,
inhibition of the HSP70 activity results in a significant accumu-
lation of Atx3 when co-transfected with mock vector, HSJ1a or
HSJ1a-UIM
mut, but it has no such effect on the cells co-transfected
with HSJ1a-JD
mut, a mutant with co-chaperone deficiency (Fig. 5B
Figure 2. The J-domain of HSJ1a decreases the protein level of Atx3 through its chaperone binding. A, Interaction of HSJ1a with HSP70
by GST pull-down experiment. GST fused J-domain or its mutant (JD
mut, H31Q/D33N) was applied to pull down HSP70, and GST was as a control.
B, Effects of JD and its mutant on the Atx3 levels. Equal amounts of the plasmids encoding HSJ1a or its fragments and Atx322Q were co-transfected
into HEK 293T cells. After transfection (48 hrs), the protein levels were detected by immunoblotting. C, The protein level of Atx322Q affected by the
J-domain is dose-dependent. The Atx322Q amounts were assayed by Western blotting under co-expression of different dose of JD or JD
mut in HEK
293T cells. D, Quantitative analysis of the Atx322Q level. The data are from (C) by using Scion Image and shown as means 6 S.D. (n=3).
doi:10.1371/journal.pone.0019763.g002
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degradation of Atx3 modulated by HSJ1a.
CHIP is also involved in the HSJ1a-modulated
degradation of Atx3
CHIP is an E3 or E4 ligase for ubiquitination; its TPR domain
can interact with the C-terminal EEVD motif of HSP70
[40,41,42]. Many studies on the function of CHIP have linked
HSP70 to the Ub-proteasome system [26,43,44,45]. It was
previously reported that overexpression of CHIP increases the
ubiquitination and degradation rates of polyQ-expanded Atx3,
which is also enhanced by HSP70 [26]. This indicates that Atx3 is
a potential substrate of HSP70. Indeed, our data show that
overexpression of HSP70 or CHIP leads to the up-regulation of
the ubiquitination level and down-regulation of the Atx3 level (Fig.
S4). Without HSP70, CHIP can ubiquitinate Atx3 in vitro, but with
a rather low efficiency. Interestingly, HSP70 can dramatically
enhance the ubiquitination efficiency of Atx3 (Fig. 6A). Deletion of
the CHIP-binding motif in the C-terminus of HSP70 (HSP70-631
or HSP70-610, residues 1-631 or 1-610) results in loss of the ability
of CHIP as an E3 ligase to promote ubiquitination of Atx3.
Besides HSP70, HSP90 is another chaperone also harboring an
EEVD motif for CHIP binding. However, HSP90 has no such
effect on promoting ubiquitination (Fig. 6B). Actually, HSJ1a is
prior to binding with HSP70 when both chaperones are present in
cells (Fig. 6C), even though HSJ1a can interact with HSP70 and
HSP90, respectively (Fig. 2A, Fig. S5) [27]. These results suggest
that down-regulation of the Atx3 level by the J-domain of HSJ1a is
mediated by HSP70 rather than HSP90. Next, we tested whether
HSJ1a, CHIP, HSP70 and Atx3 can form a complex in cells. We
overexpressed FLAG-Atx3, HA-HSP70 and Myc-HSJ1a or Myc-
CHIP in HEK 293T cells for co-IP experiments. The data show
that HSJ1a can precipitate both HSP70 and Atx3 (Fig. 6C), while
CHIP can also precipitate HSP70 but a trace amount of Atx3
(Fig. 6D). This may be attributable to the quantitative difference
and transient interaction between the substrates and E3 ligase. A
reverse co-IP experiment shows that a considerable amount of
CHIP can be precipitated by Atx3 (Fig. 6D). These results provide
a possibility that HSP70 and its co-chaperones, HSJ1a and CHIP,
work together to regulate the degradation of Atx3.
Figure 3. Effects of HSJ1a and its mutants on the Atx3 levels. A, Different effects of HSJ1a and its mutants on the Atx3 level. HA-
Atx322Q and Myc-HSJ1a or its mutants (with half DNA amount) were co-transfected into HEK 293T cells, and then 48 hrs after transfection the cell
lysates were subjected to immunoblotting with anti-HA and anti-Myc antibodies. B, Effects of HSJ1a and its mutants on the Atx3 levels by dose-
dependent analysis. HA-Atx322Q and different dose of Myc-HSJ1a or its mutants were co-transfected to HEK 293T cells. The DNA amounts of HSJ1a or
its mutants are 0, 0.05, 0.1, 0.2, 0.4 and 2 mg, respectively. C, Immuno-fluorescence imaging of the cellular protein levels of Atx3 regulated by HSJ1a
and its mutants. Atx3 is stained with anti-HA antibody (green), HSJ1a and its mutants are stained with anti-Myc antibody (red), and nuclei are stained
with Hoechst (blue). Scale bar=20 mm.
doi:10.1371/journal.pone.0019763.g003
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ubiquitinate Atx3 in vitro, we still wonder whether CHIP is
directly involved in the degradation of Atx3. We thus knocked
down CHIP expression by using siRNA in HEK293T cells. As a
result, silencing of CHIP significantly increases the amount of
Atx3 (Fig. 6E), suggesting that CHIP may down-regulate the Atx3
level. Next we examined whether CHIP regulates Atx3 through
HSJ1a. When co-transfected with HSJ1a or its mutants, the
amount of Atx3 increases in the context of CHIP silencing
(Fig. 6F, 3
rd panel). A decrease of the ubiquitinated conjugates
precipitated by Atx3 is also observed as compared with the
siRNA control (1
st panel). To further demonstrate this observa-
tion, we used an Atx3 mutant (Atx3-UIM
mut) to repeat this
experiment. As mentioned above (Fig. S3), Atx3-UIM
mut loses
the potential to bind with polyUb chains, so the ubiquitinated
conjugates precipitated by this mutant are mostly the ubiquiti-
nated form of Atx3. Indeed, the amount of the ubiquitinated
conjugates, which was maintained by HSJ1a, was significantly
reduced when CHIP silencing (Fig. 6G). Collectively, these results
demonstrate that CHIP is directly involved in the degradation of
Atx3 regulated by HSJ1a.
HSJ1a can also dually regulate polyQ-expanded Atx3
through HSP70-assisted proteasomal degradation
pathway
It is generally accepted that polyQ expansion of proteins is
associated with the pathogenesis of some neurodegenerative
diseases [46]. There is a report that HSJ1a can reduce polyQ-
mediated inclusion body formation in a model of spinal and bulbar
muscular atrophy (SBMA) [47]. Similarly, we also observed in
HEK 293T cells that endogenous HSP70 and HSJ1 are recruited
into the nuclear inclusion bodies formed by polyQ-expanded Atx3
(Atx371Q) (Fig. S6). To understand whether HSJ1a regulates the
metabolism of the pathogenic form of Atx3, we performed the
experiments on the polyQ-expanded Atx371Q. Overexpression of
HA-tagged Atx371Q causes inclusion body formation in cells
(Fig. 7A), which can be alleviated by overexpression of HSJ1a, the
JD or DJD fragment, although both HSJ1a and its DJD fragment
increase the Atx371Q levels (Fig. 7B). As in the case of Atx322Q
(Fig. 1, 2 & 3), the cellular protein levels of Atx371Q are also
modulated by HSJ1a and its fragments (Fig. 7B & 7C), in which
deletion and mutation in the J-domain or UIM domain of HSJ1a
give rise to similar effect on the protein levels of Atx371Q in cells
Figure 4. HSJ1a regulates the proteasomal degradation of Atx3. A, Effects of proteasome or lysosome inhibitors on the HSJ1a-modulated
protein level of Atx3. Equal amounts of HA-Atx3 and Myc-HSJ1a-UIM
mut or mock vector were co-transfected into HEK 293T cells. After transfection
(36 hrs), the cells were treated with 10 mM lactacystine or leupeptin (proteasome inhibitor) or 2 mM NH4Cl (lysosome inhibitor) for 10 hrs. Then the
cell lysates were subjected to immunoblotting with anti-HA, anti-Myc or anti-actin antibody. B, Effect of proteasome inhibitor MG132 on the HSJ1a-
modulated protein level of Atx3. Equal amounts of HA-Atx3 and Myc-HSJ1a, Myc-HSJ1a-JD
mut, Myc-HSJ1a-UIM
mut or mock vector were co-transfected
into HEK 293T cells. After 36 hrs, the cells were treated with 10 mM MG132 for 10 hrs. C, Quantitative analysis of the Atx322Q level. The data are from
(B) by using Scion Image and shown as means 6 S.D. (n=3). ** p,0.01. D, Ubiquitination of Atx3 affected by HSJ1a and its mutants. The cell lysates
as shown in (B) were subjected to immunoprecipitation with anti-HA antibody and the resulting precipitates were subjected to immunoblotting with
anti-Ub antibody (upper panel). The total ubiquitination of the lysates is shown as a control (middle panel). The asterisks denote the bands from the
heavy and light chains of IgG.
doi:10.1371/journal.pone.0019763.g004
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proteasome activity can also significantly increase the protein level
of Atx371Q (Fig. 7D), as in the case of Atx322Q (Fig. 4 & 5). All
these experimental data demonstrate that, similar with that of
normal Atx3, the protein level of pathogenic Atx3 is also regulated
by HSJ1a through an HSP70-assisted proteasomal degradation
pathway. This study may provide a possibility therapeutically for
eliminating the cellular inclusion bodies formed by polyQ-
expanded Atx3 though interfering with the functionality of the
two domains in the HSJ1a co-chaperone.
Discussion
Overexpression of Atx3 and cell stress response
In eukaryotic cells, the amount of a protein must be maintained
to a relatively stable level by diverse regulatory processes. Loss of
this regulation may cause protein accumulation and even
abnormal aggregation or inclusion formation, and consequently
lead to stress response [2,48]. It was previously reported that
overexpression of abnormal Atx3 can evoke a stress response in
cells as manifested by marked induction of HSP70 [9]. The
overexpressed Atx3 may cause a proteotoxic stress in cells and it
will be eliminated (or refolded) by HSP70 chaperone machinery.
Thus, it is very important for a cell to respond the overexpression
stress. Molecular chaperones such as HSP70 may act as a sensor of
the abnormal proteins by recognize the misfolded or aggregated
proteins [2]. The data from our study and other literatures
implicate that the overexpressed Atx3 is a potential substrate of
HSP70 and thus orchestrated by HSJ1a [26,49]. However, HSJ1a
cannot regulate the endogenous Atx3 (Fig. S8), possibly because
Atx3 with normal amount is correctly folded that cannot be
censored by HSP70. Thus, we propose that HSP70 is a key
molecular factor to censor the overexpressed Atx3 and trigger the
cell stress response.
HSJ1a binds HSP70 and promotes proteasomal
degradation of Atx3
HSJ1a is a J-domain containing co-chaperone of HSP70 that
binds with HSP70 and stimulates its ATPase activity for
modulating its functionality [21]. Molecular chaperones and their
co-chaperones, such as HSP70, HSP40 and CHIP, may function
in modulating aggregation, cytotoxicity, and disease onset in
polyQ diseases [9,25,26,50,51,52]. Recently, HSP70 and CHIP
have been proposed to regulate the proteasomal degradation of
polyQ-expanded proteins including Atx3 [26,49]. Our studies
both in vitro and in cell model demonstrate that the N-terminal J-
domain of HSJ1a binds HSP70 and enhances proteasomal
degradation of Atx3 (Fig. 3 & 7). HSP70 dramatically promotes
the ubiquitination efficiency of overexpressed Atx3 in the presence
of CHIP (Fig. 6), while inhibition of the ATPase activity of HSP70
as well as proteasome significantly accumulates the ubiquitinated
Atx3 (Fig. 4 & 7). Therefore, the overexpressed Atx3, whether it is
normal or polyQ expanded, is an HSP70 client and subsequently
the substrate of HSP70-assisted proteasomal degradation. As a co-
chaperone of HSP70, HSJ1a functions as a modulator to regulate
this process.
HSJ1a binds ubiquitinated Atx3 and retards its
degradation
HSJ1a also harbors two UIM motifs that may function in
binding with Ub chains or ubiquitinated substrates. Our
Figure 5. HSP70 is directly involved in the HSJ1a-modulated proteasomal degradation of Atx3. A, Effect of inhibiting the ATPase activity
of HSP70 on the Atx322Q level. HA-Atx322Q was transfected into HEK 293T cells, and then 24 hrs after transfection the cells were treated with 50 mM
Azure C or 20 mM MG132 for 10 hrs. The cell lysates were subjected to immunoblotting with anti-HA antibody. B, Effects of HSP70 inhibition on the
HSJ1a-modulated Atx3 levels. HA-Atx322Q and Myc-tagged HSJ1a, HSJ1a-JD
mut, HSJ1a-UIM
mut or mock vector were co-transfected into HEK 293T cells,
and 24 hrs later, the cells were treated with 50 mM Azure C or MG132 for 10 hrs. C, Quantitative analysis of the Atx322Q level. The data are from (B) by
using Scion Image and shown as means 6 S.D. (n=3). ** p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0019763.g005
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Atx3 (arrow indicated) and its ubiquitinated forms (bracket indicated) were detected by immunoblotting with an anti-Atx3 antibody. B, In vitro
ubiquitination of Atx3 mediated by HSP70 and HSP90. The reaction products were detected as in (A). The GB1-tagged HSP90 was used in this study
for the sake of protein stability. The asterisk denotes GB1-HSP90, in which GB1 can be detected by the antibody. C, Co-IP experiments for interactions
of HSJ1a with HSP70 or HSP90 and Atx3. HEK 293T cells were co-transfected with HSJ1a-Myc, HA-HSP70 and HA-HSP90 or FLAG-Atx3, the cell lysates
were subjected to co-immunoprecipitation. IP, anti-Myc antibody; IB, anti-HA, anti-Myc and anti- FLAG antibodies. D, Co-IP experiments for the
ternary complex among interactions of CHIP, HSP70 and Atx3. HEK 293T cells were co-transfected with HSJ1a-Myc or Myc-CHIP, HA-HSP70 and FLAG-
Atx3, and then the cell lysates were subjected to co-IP experiment. IP, anti-Myc or anti-FLAG antibody; IB, anti-HA, anti-FLAG and anti-Myc antibodies.
E, Knockdown of CHIP increases the level of overexpressed Atx3. HEK 293T cells were transfected with scrambled or CHIP siRNA and HA-Atx3. The
protein levels of Atx3 and endogenous CHIP were measured by immunoblotting with anti-HA and anti-CHIP antibodies. F & G, knockdown of CHIP
lowers down the amount of ubiquitinated Atx3 (F) or Atx3-UIM
mut (G) maintained by HSJ1a or HSJ1a-JD
mut. HEK 293T cells were transfected with
scrambled or CHIP siRNA and indicated expression vectors. The cell lysates were subjected to immunoprecipitation with anti-HA antibody and the
resulting precipitates were subjected to immunoblotting with anti-Ub antibody (upper panel). The lysates were also subjected to immunoblotting
with anti-HA, anti-CHIP, anti-actin and anti-Myc antibodies.
doi:10.1371/journal.pone.0019763.g006
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accumulate the ubiquitinated Atx3 and impede it from proteaso-
mal degradation (Fig. 4, 5 & 7). This is generally consistent with
the previous observation that HSJ1a can accumulate ubiquitinated
proteins [47]. As known, the J-domain of HSJ1a rather than the
UIM domain exerts a function down-regulating the protein level
of Atx3. The UIM domain of HSJ1a actually finely decelerates the
degradation process by accumulating the ubiquitinated Atx3.
It was reported that HSJ1a can stimulate CHIP-mediated
ubiquitination of Raf-1, and the UIM domain is not responsible
for this stimulation [30]. Our in vitro study indicates that HSJ1a
can inhibit the CHIP-mediated ubiquitination of Atx3 depending
on the UIM domain, whereas the J-domain cannot promote the
process (Fig. S9). It is possible that the J-domain of HSJ1a
enhances the degradation of Atx3 through assisting release of the
ubiquitinated Atx3 from the HSP70-CHIP complex, instead of
promoting its ubiquitination. The UIM domain may prevent the
degradation of Atx3 through binding with the ubiquitinated Atx3
and inhibiting its further ubiquitination in cells.
HSJ1a is a dual regulator of the cellular Atx3 level
One of the important issues involved in HSP70-assisted
proteasomal degradation is that how a chaperone cooperates with
UPS. Actually, it is the co-chaperones that act as bridges to link
these two systems. Among the diverse co-chaperones of HSP70 yet
identified, several proteins harbor both chaperone and Ub related
Figure 7. HSJ1a can also dually regulate the protein level of the polyQ-expanded Atx3 (Atx371Q) in cells. A, Immuno-fluorescence
imaging of the cellular inclusions formed by Atx371Q regulated by HSJ1a and its fragments. B, Effects of HSJ1a and its fragments on the protein levels
of Atx371Q. HA-tagged Atx371Q and Myc-HSJ1a or its fragments (with half DNA amount) were co-transfected into HEK 293T cells. About 48 hrs after
transfection, the cell lysates were subjected to immunoblotting with anti-HA, anti-Myc or anti-actin antibody. Atx371Q, polyQ-expanded Atx3 with
71 Gln residues. C, Different effects of HSJ1a and its mutants on the protein level of Atx371Q. HA-Atx371Q and Myc-HSJ1a or its mutants (with half DNA
amount) were co-transfected into HEK 293T cells, and then 48 hrs after transfection the cell lysates were subjected to immunoblotting with anti-HA
and anti-Myc antibodies. D, Effect of inhibiting the ATPase activity of HSP70 on the Atx371Q level. HA-Atx371Q was transfected into HEK 293T cells, and
then 24 hrs after transfection the cells were treated with 50 mM Azure C or 20 mM MG132 for 10 hrs. The cell lysates were subjected to
immunoblotting with anti-HA antibody.
doi:10.1371/journal.pone.0019763.g007
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include BAG-1 (BAG-UbL) [53], BAG-6/BAT3 (UbL-BAG) [54],
Sacsin (JD-UbL) [55], and the well-characterized CHIP (TPR-
Ubox) [56]. These co-chaperones have great potential to play
important roles in the protein quality control processes through
linking the chaperone system and UPS. In this study, we
demonstrate that co-chaperone HSJ1a can dually regulate
degradation of Atx3, and even eliminate the inclusion bodies
formed by polyQ expanded Atx3 (Fig. 7A) and another polyQ
disease-related protein Atx7 (data not shown) in cells. The J-
domain and the UIM domain play distinct roles in this particular
process. Interestingly, the increasing level of polyQ-expanded Atx3
caused by the DJD fragment does not result in an increase of the
inclusions (Fig. 7A).
HSJ1a regulates the Atx3 level in a Yin-Yang manner
Our findings demonstrate that the N-terminal J-domain of
HSJ1a promotes proteasomal degradation of Atx3, whereas the C-
terminal UIM domain alleviates the degradation. In this regard,
HSJ1a may exert a role deciding whether a chaperone client to be
degraded in proteasome or to be stayed in its ubiquitinated form
[14]. Thus, we propose that HSJ1a dually regulates the protein
level of Atx3 in stressed cells in a Yin-Yang manner, no matter it is
normal or polyQ expanded (Fig. 8). In this model, the chaperone
HSP70 recruits the E3 ligase CHIP to ubiquitinate Atx3, while the
co-chaperone HSJ1a enhances the function of the HSP70 complex
to eliminate the overexpressed substrate. The J-domain of HSJ1a
binds with HSP70 to promote the chaperone-assisted proteasomal
degradation of the substrate, as in the case of HSP40 that
associates with HSP70 to reduce aggregation of Atx3 [9]. On the
other hand, HSJ1a can also impede the proteasomal degradation
of the ubiquitinated Atx3 to maintain the protein level when
needed. The UIM domain of HSJ1a may bind with and stabilize
the ubiquitinated Atx3, so as to protect it from degradation. These
two distinct processes make HSJ1a a dual regulator to maintain
the homeostasis of Atx3 molecules. Impairment of the protein
homeostasis may cause a pathogenic phenotype, for example
formation of inclusion bodies [2]. Thus, finely modulating the
balance of the functions of two HSJ1a domains could be
considered as a promising therapeutic strategy for neurodegener-
ative diseases [1].
Materials and Methods
Construction of the expression plasmids
The coding sequence for HSJ1a was referred to GenBank
(AAA09034.1). The cDNAs encoding for HSJ1a (residues 1-274),
JD (1-91), DJD (91-274), and UIM12 (206-272) were amplified via
PCR. The PCR products were cloned into pGEX-4T-3 or
pGBTNH [57] vector for bacterial expression or pcDNA3.1-Myc/
His vector for eukaryotic expression using BamHI / Xho I cloning
sites. HSJ1a-JD
mut (H31Q/D33N) and HSJ1a-UIM
mut (S219A/
E222A/S262A/E265A) were prepared using site-directed muta-
genesis via PCR technique. The genes encoding for Atx3 (22Q or
71Q) and its mutant (S236A/S256A) [35] were cloned into
pcDNA3-HA vector using BamHI / Xho I cloning sites to get HA-
tagged proteins or cloned into pEGFPN1 vector using Xho I/
BamH I cloning sites to get GFP-tagged proteins. HSP70 was
cloned into pET22b
+ expression vector to get bacterially expressed
proteins and then inserted into pcDNA3-HA to get HA-HSP70.
CHIP was cloned to pET22b
+ vector for bacterial expression or
pcDNA3.1-Myc/His for eukaryotic expression. All constructs were
confirmed by DNA sequencing.
Protein expression and purification
The genes encoding His-tagged or GST fusion proteins were
expressed in E. coli BL21 (DE3) cells. The His-tagged proteins
were purified through a Ni
+-NTA column (Qiagen) according to
manufacturer’s instructions. GST and the GST fusion proteins
were purified using the glutathione Sepharose 4B column
(Amersham Biosciences). The
15N- and
15N/
13C-labeled GB1-
HSJ1a-UIM12 proteins were prepared by using the M9 minimal
medium containing
15N-NH4Cl and/or
13C6-D-glucose, and were
purified by Ni
+-NTA affinity column. All the proteins were further
purified by a Superdex-75 column (GE Healthcare).
GST pull-down experiment
The purified GST or GST-JD protein was incubated with
glutathione Sepharose 4B beads in a PBS buffer (10 mM
Na2HPO4, 140 mM NaCl, 2.7 mM KCl, 1.8 mM KH2PO4,
pH 7.3) at 4uC for 1 hr. The His-tagged proteins were incubated
with the immobilized GST or GST-fusion proteins at 4uC. After
incubating for 2 hrs, the beads were collected by centrifugation
and washed 4 times with the same buffer. The samples were then
subjected to SDS-PAGE, followed by Coomassie blue staining.
Cell culture and transfection
HEK 293T cells (American Type Culture Collection, Manassas,
VA, USA) were cultured in Dulbecco’s modified Eagle’s medium
(DMEM)/F-12 (Invitrogen) supplemented with 10% fetal bovine
serum (Hyclone), penicillin, and streptomycin and grown at 37uC
under a humidified atmosphere containing 5% CO2 [58]. The
cells were transfected with the expression vectors by using
FuGENEHHD Transfection Reagent (Roche) following the
manufacturer’s instructions. MG132 and lactacystine were
Figure 8. Schematic representation of the proteasomal degra-
dation of Atx3 showing different roles of the two domains of
HSJ1a. This model proposes that HSJ1a acts like a balance
orchestrating the cellular level of Atx3. The J-domain promotes the
proteasomal degradation of Atx3 through HSP70 binding, whereas the
UIM domain retards the proteasomal degradation of Atx3 through
ubiquitin binding. HSP70 acts as an adaptor to recruit co-chaperones
and the substrates.
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blue were purchased from Sigma. For inhibition experiment,
about 24 hrs after transfection, the cells were treated with different
inhibitors for 10,16 hrs before lysis. The siRNA target sequence
for CHIP is 59-GUGGCAAGAUCAGCUUUGA-39, and the
siRNA control sequence is 59-UUCUCCGAACGUGUCACGU-
39. The cells were transfected with the duplex siRNA using
lipofectamine 2000 (Invitrogen) following the manufacture’s
instructions.
Western blotting and antibodies
The cells were harvested 48 hrs after transfection and lysed in
RIPA buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1 mM PMSF, cocktail protease inhibitor (Roche), 1% NP-
40), and then the lysates were subjected to SDS-PAGE with 10%,
12% or 15% acrylamide gels and transferred onto PVDF
membranes (PerkinElmer). The indicated proteins were probed
with the following primary antibodies: mouse monoclonal
antibodies against HA (Sigma), FLAG (Sigma), Myc (Cell
Signaling), His (Sigma), Ub (Santa Cruz) and Atx3 (Chemicon);
goat anti-actin antibody (Santa Cruz), rabbit polyclonal anti-Myc
antibody (Cell Signaling), rabbit polyclonal anti-HSP70 antibody
(Proteintech), rabbit polyclonal anti-CHIP (Sigma), mouse mono-
clonal antibody against inducible HSP70 (Abcam). The goat anti-
mouse IgG-HRP antibody, goat anti-rabbit IgG-HRP and rabbit
anti-goat IgG-HRP secondary antibodies (Jackson Immuno-
Research) were also used. The proteins were visualized using an
ECL detection kit (Amersham Pharmacia Biotech).
Immunoprecipitation, Immunocytochemistry, and
confocal microscopy
The HEK 293T cells were lysed in RIPA buffer for 30 min on
ice and then the lysates were incubated with an antibody for 2 hrs
at 4uC. After incubation, the protein A/G beads (GE Healthcare)
were added for another 4 hrs at 4uC. The beads were washed with
lysis buffer for four times, and the precipitated proteins were
subjected to immunoblotting analysis.
The HEK 293T cells grown and transfected on cover slides
were washed with PBS buffer and fixed with 4% paraformalde-
hyde for 10 min and permeabilized with 0.1% Triton X-100 for
1 min, and then blocked with 5% BSA/1% FBS for 1 hr at room
temperature. The fixed cells were incubated for 1 hr at room
temperature with a combination of a monoclonal antibody against
HA (Sigma) and a polyclonal antibody against Myc (Cell
Signaling). After washing with PBS, the cells were labeled with
an FITC-conjugated anti-mouse antibody and a Cyanine 3
conjugated anti-rabbit secondary antibody (Jackson Immuno-
Research) [58]. The nuclei were stained with Hoechst (Sigma).
The cells were visualized with a Leica TCS SP2 confocal
microscope (Leica Microsystems).
In vitro ubiquitination assay
The Atx3-His protein and 0.1 mM mouse UbE1 (previously
prepared in this lab), 2.4 mM UbcH5C, 1 mM CHIP, 5 mM Ub,
2 mM ATP with or without 1 mM HSP70 (or HSP90) were mixed
in a reaction buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.6) and
incubated for 1 hr at 37uC. The reactions were stopped by adding
the sample buffer for SDS-PAGE and then detected by
immunoblotting analysis.
Supporting Information
Figure S1 Effects of HSJ1a and its fragments on the mRNA
levels of Atx3. (A) Sequences and domain architecture of HSJ1a
and its fragments and mutants. (B) Quantitative real-time PCR
analysis of Atx3 mRNA levels in HEK 293T cells transiently
transfected with the indicated plasmids as shown. Shown are
means 6 S.D. (n=3). JD, J-domain fragment; DJD, J-domain
deleted fragment.
(PDF)
Figure S2 Interactions between the UIM12 domain of HSJ1a
and different diUb chains. (A) ITC experiment for the interaction
of GB1-UIM12 with K48-diUb. The concentration of diUb is
100 mM and that of the GB1-UIM12 stock is 2 mM. The data are
fitted with the one-site binding model. The GB1 fusion was used
for purification and quantification. (B) As (A), with K63-diUb. (C)
NMR titration of GB1-UIM12 with K48-diUb. Shown is the
overlay of the
1H-
15N HSQC spectra of
15N-labeled GB1-UIM12
before (green) and after (red) addition of 1 equiv. of K48-diUb. (D)
As (C), with K63-diUb. Shown is the overlay of the
1H-
15N HSQC
spectra of
15N-labeled GB1-UIM12 before (blue) and after (red)
addition of 1 equiv. of K63-diUb. (E) Plot of the relative peak
heights against the residue number of GB1-UIM12 titrated with 1
equiv. of K48-diUb. All the peak heights were normalized except
for prolines and unassigned residues. The diagram shows the peak
heights for the residues from GB1 (yellow), UIM1 (blue), the linker
(purple) and UIM2 (blue). (F) Co-IP experiment for interaction
between HSJ1a or its UIM mutant and endogenous Ub chains.
HEK 293T cells were transiently transfected with a vector
expressing His-HSJ1a or His-HSJ1a-UIM
mut. After 48 hrs, the
cells were subjected to immunoprecipitation (IP) with anti-His and
the resulting precipitates were subjected to immunoblotting (IB)
with either anti-Ub or anti-His. The asterisks denote the bands
from the heavy and light chains of IgG.
(PDF)
Figure S3 HSJ1a exerts the similar effect on the UIM mutant
form of Atx3. (A) Different effects of HSJ1a and its mutants on the
protein levels of Atx3-UIM
mut. HA-Atx3-UIM
mut and Myc-HSJ1a
or its mutants were co-transfected into HEK 293T cells. About
48 hrs after transfection, the cell lysates were subjected to
immunoblotting with anti-HA and anti-Myc antibodies. (B)
Ubiquitination of Atx3-UIM
mut affected by HSJ1a and its
mutants. The cell lysates as shown in (A) were subjected to IP
with anti-HA antibody and the resulting precipitates were
subjected to IB analysis with anti-Ub antibody (upper panel) or
anti-HA antibody (lower panel). The control lane represents the
background of immunoblotting by using the HA antibody (without
cell lysates).
(PDF)
Figure S4 Hsp70 and CHIP regulate the degradation of Atx3.
(A) HA-Atx3 and different amount of HA-HSP70 (0, 0.05, 0.1,
0.2, 0.4, 2 mg of DNA) were co-transfected into HEK 293T cells.
After 48 hrs, the cell lysates were subjected to immunoblotting
with indicated antibody. (B) As (A), with Myc-CHIP (0, 0.5, 1,
2 mg of DNA). (C) Equal amount of HA-tagged Atx3 and Myc-
CHIP were co-transfected to HEK 293T cells. After 36 hrs, the
cells were treated with 20 mM MG132 for 10 h, and then the cell
lysates were subjected to immunoblotting with anti-Atx3
antibody.
(PDF)
Figure S5 Interaction between HSP90 and HSJ1a. (A) Co-IP
experiment for interaction of HSJ1a with HSP90. The cell lysates
with indicated proteins were subjected to co-IP with anti-His
antibody and the resulting precipitates were subjected to
immunoblotting with anti-HA (HSP90) and anti-Myc (HSJ1a)
antibodies. (B) As (A), with anti-HA antibody for immunoprecip-
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immunoblotting.
(PDF)
Figure S6 Co-localization of the inclusion bodies formed by
polyQ-expanded Atx3 with endogenous HSP70 or HSJ1a. HEK
293T cells were transiently transfected with the vector expressing
HA-Atx371Q. After 48 hrs, the cells were subjected to immuno-
fluorescence staining with anti-HSP70 (red) or anti-HSJ1a (red)
and anti-HA (green) antibodies. Nuclei are stained with Hoechst
(blue). Scale bar=20 mm.
(PDF)
Figure S7 Effects of HSJ1a and its mutants on the protein levels
of polyQ-expanded Atx3. (A) Effects of HSJ1a and its fragments
on the protein levels of Atx371Q. HA-tagged Atx371Q were co-
transfected with Myc-HSJ1a or its fragments in HEK 293T cells.
About 48 hrs after transfection, the cell lysates were subjected to
immunoblotting with anti-HA, anti-Myc and anti-actin antibodies.
Atx371Q, polyQ-expanded Atx3 with 71 Gln residues. (B) Effects
of HSJ1a and its mutants on the Atx371Q levels in a dose-
dependent manner. HA-Atx371Q and different amounts of Myc-
HSJ1a or its mutants were co-transfected into HEK 293T cells.
The amounts of plasmid DNA are 0, 0.5 and 2 mg, respectively.
(C) Immuno-fluorescence imaging of the cellular protein levels of
Atx371Q regulated by HSJ1a and its mutants. Atx371Q is stained
with anti-HA antibody (green), HSJ1a and its mutants are stained
with anti-Myc antibody (red), and nuclei are stained with Hoechst
(blue). Scale bar=20 mm.
(PDF)
Figure S8 HSJ1a and its mutants exert no effect on the protein
level of endogenous Atx3. Myc-tagged HSJ1a, HSJ1a-JD
mut,
HSJ1a-UIM
mut and empty vector were transfected into HEK
293T cells. About 48 hrs after transfection, the cell lysates were
subjected to immunoblotting with anti-Atx3, anti-Myc and anti-
actin antibodies.
(PDF)
Figure S9 Ubiquitination of Atx3 in an in vitro system. (A) The
ubiquitination of Atx3 was performed in a reaction mixture of
UbE1, UbcH5C, Ub, ATP, and the HEK 293T cell lysates
containing GST, GST-HSJ1a or its mutants. Atx3 and its
ubiquitinated forms were detected by immunoblotting with an
anti-Atx3 antibody. (B) The ubiquitination of Atx3 was performed
in a reaction mixture of purified proteins as indicated. The
reaction products were detected as in (A). The arrows denote the
bands of Atx3 and HSJ1a without ubiquitination.
(PDF)
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